Wilms Tumor: 200 Years of Progress - Ron Lemire Lecture
Objectives and Disclosures
Participants will be able to:
- Assess the importance of pathologic evaluation, clinical evaluation and molecular diagnostics in the approach to children with Wilms tumor.
- Distinguish favorable from unfavorable forms of Wilms tumor.
- Specify syndromes which convey higher risks of developing Wilms tumor.
Seattle Children’s CME Planners and today’s speaker disclose they have no relevant financial relationships.
Speaker(s)
Bruce R. Pawel, MD
Chief of Anatomic Pathology, Children’s Hospital Los Angeles; Professor of Clinical Pathology, Keck School of Medicine at the University of Southern California, Department of Pathology and Laboratory Medicine
Date
11.7.24CME Credit
Seattle Children’s is accredited by the Washington State Medical Association CME Accreditation Committee to sponsor continuing medical education for physicians.
Seattle Children’s designates this online educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 1 hour of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Videos are available for only one year after posting.
If you wish to receive Category I CME credit for viewing this Provider Grand Rounds session, please complete the evaluation form. Upon completion of the form you will receive an auto-reply email that will serve as the only confirmation of your CME credit. Please keep the email for your records.